Suppr超能文献

他汀类药物的替代物还是仅仅是安慰剂:对ω-3脂肪酸、红曲米和大蒜在心血管治疗中的客观综述。

Statin alternatives or just placebo: an objective review of omega-3, red yeast rice and garlic in cardiovascular therapeutics.

作者信息

Ong Hean Teik, Cheah Jin Seng

机构信息

HT Ong Heart Clinic, Penang, Malaysia.

出版信息

Chin Med J (Engl). 2008 Aug 20;121(16):1588-94.

Abstract

OBJECTIVE

The aim of this review is to objectively access the trial evidence on the role of omega-3, red yeast rice and garlic in preventing clinical cardiovascular events. Given the large number of clinical trials favoring statin use in cardiovascular disease, it is important to see if evidence is available for these supplements and whether they could replace statin therapy.

DATA SOURCE

A PubMed search was conducted using the keywords 'trial, omega-3, red yeast rice, xuezhikang, garlic, cholesterol, cardiovascular, outcomes'; the resulting trials were reviewed together with the references quoted in the papers obtained.

STUDY SELECTION

The studies selected are prospective, randomized, placebo-controlled studies with predefined clinical cardiovascular end-points recruiting at least 2000 patients, with a follow-up over 2 years.

RESULTS

Modest dose omega-3 fatty acid has been shown in GISSI-P (11 324 patients, follow-up 3.5 years) to produce a reduction in sudden death of 45%, and in cardiac death of 35%, acting probably via an anti-arrhythmic effect. In JELIS (18 645 patients, follow-up 4.6 years), high dose omega-3 given to Japanese patients on a high fish diet and already on statin treatment produced further benefit with a 19% reduction of nonfatal cardiovascular outcomes; fatal cardiac events are not affected. CCSPS (4870 patients, follow-up 4 years), a secondary prevention trial using xuezhikang, a commercial red yeast rice preparation, produced a 46% reduction in nonfatal myocardial infarction and coronary death. There has been no trial to show that garlic reduces clinical cardiovascular outcomes. A rigorous trial with constant assessment of chemicals in the study material in 192 patients found that over a 6-month follow-up, raw garlic and 2 commercial preparations do not significantly affect lipid levels.

CONCLUSIONS

Omega-3 in modest doses reduces cardiac deaths, and in high doses reduces nonfatal cardiovascular events. Red yeast rice reduces adverse cardiac events to a similar degree as the statins. It is unlikely that garlic is useful in preventing cardiovascular disease.

摘要

目的

本综述旨在客观评估关于ω-3、红曲米和大蒜在预防临床心血管事件中作用的试验证据。鉴于大量临床试验支持他汀类药物用于心血管疾病治疗,了解这些补充剂是否有可用证据以及它们能否替代他汀类药物治疗很重要。

数据来源

使用关键词“试验、ω-3、红曲米、血脂康、大蒜、胆固醇、心血管、结局”在PubMed上进行检索;对检索到的试验以及所获论文中引用的参考文献进行综合审查。

研究选择

所选研究为前瞻性、随机、安慰剂对照研究,具有预先定义的临床心血管终点,招募至少2000名患者,随访超过2年。

结果

在GISSI-P研究(11324例患者,随访3.5年)中,中等剂量的ω-3脂肪酸可使猝死率降低45%,心脏性死亡率降低35%,其作用可能是通过抗心律失常效应实现的。在JELIS研究(18645例患者,随访4.6年)中,给食用高鱼类饮食且已接受他汀类药物治疗的日本患者服用高剂量ω-3可进一步获益,非致死性心血管事件减少19%;致命性心脏事件未受影响。CCSPS研究(4870例患者,随访4年)是一项使用血脂康(一种市售红曲米制剂)的二级预防试验,可使非致死性心肌梗死和冠状动脉死亡减少46%。尚无试验表明大蒜能降低临床心血管事件发生率。一项对192例患者进行研究材料中化学物质持续评估的严格试验发现,在6个月的随访期内,生蒜和两种市售制剂对血脂水平无显著影响。

结论

中等剂量的ω-3可降低心脏性死亡,高剂量可降低非致死性心血管事件。红曲米降低不良心脏事件的程度与他汀类药物相似。大蒜不太可能对预防心血管疾病有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验